Global Neonatal Journal Club is now available for online viewing! Click the link HERE to watch now
Password: GNJC
Neena Modi is Professor of Neonatal Medicine and Vice-Dean (International) in the Faculty of Medicine, Imperial College London and Consultant in Neonatal Medicine at Chelsea and Westminster NHS Foundation Trust.
Neena is a Fellow of the Academy of Medical Sciences and Council member 2020-23. She heads the multidisciplinary Neonatal Medicine Research Group, and the National Neonatal Research Database, a UK Information Asset, at the Neonatal Data Analysis Unit, at Imperial. She is the lead for the "Pregnancy and Prematurity" theme of the National Institute for Health Research Imperial Biomedical Research Centre.
Neena has a national and international profile as a medical leader and clinical scientist. She is the current president of the European Association for Perinatal Research. She is a past-president of the British Medical Association. UK Medical Women's Federation, and UK Royal College of Paediatrics and Child Health. She has held by election, the three leading national children’s research positions in the UK, President of the Neonatal Society, President of the Academic Paediatrics Association of Great Britain and Ireland, and Royal College of Paediatrics and Child Health Vice-President for Science and Research.
Neena chaired the British Medical Journal Ethics Committee for five years and serves currently on a number of research committees and working groups. She is the current chair of the Scientific Committee of the International Paediatric Association. Her contributions have included national reports on children’s biomedical research and child health in the UK, and campaigning in relation to UK health services, environmental issues and child refugees. She led the establishment of a Child Health Research Collaboration and Children's Research Fellowship Fund. She is a trustee of the charities TheirWorld and Action Cerebral Palsy. She is an advocate for child health and well-being, and youth enfranchisement, and a campaigner for the retention of the National Health Service as a primarily publicly funded, publicly delivered healthcare system.
Peter Dargaville trained in Neonatology at the Royal Children’s Hospital, Melbourne, and at the University of California, San Francisco. His training included a two year full-time research project looking at pulmonary surfactant and its abnormalities in ventilated infants with lung disease, for which he was awarded an MD from the University of Melbourne in 2000. He now continues as a clinician-researcher at the Royal Hobart Hospital and University of Tasmania.
The major focus of his research is the development and implementation of new therapies for neonatal lung disease. He has been Chief Investigator of the NHMRC-funded OPTIMIST-A trial, a multinational RCT of minimally invasive surfactant therapy in preterm infants with RDS. Other current research themes include the detection, prediction and curtailment of apnoea in preterm infants, and the exploration of mechanisms of lung injury in the immature neonatal lung. He is co-inventor of an algorithm for automated control of oxygen therapy in infants receiving supplemental oxygen, which is now patented and commercialised.